09:46 AM EST - Aurinia Pharmaceuticals Inc. : Has completed its previously announced private placement of 3,000,000 units of the Company at $2.36 U.S. per unit for total gross proceeds of $7,080,000 U.S.. Each unit consists of one common share of the Company and a 0.35 of one common share purchase warrant exercisable for a period of two years from the date of issuance at an exercise price of $2.77 U.S. Aurinia Pharmaceuticals Inc.
shares T.AUP are trading unchanged at $3.49.
